Primary study · included by 1 review

Epigallocatechin-3-gallate inhibits osteopontin expression and prevents experimentally induced hepatic fibrosis.

George 2022 · George Joseph, Tsuchishima Mutsumi, Tsutsumi Mikihiro · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022

Included by

Chemoprophylaxis effect of EGCG on various digestive system diseases: a systematic review and meta-analysis.
Non-Cochrane · intervention · 2026 · cited as George 2022 · Reference 90

The review does not say which of its outcomes this study informs.

1 including review in total.